Healthcare provider profile · identity verified

Daniel A Rubin, MD

Family Practice · GAINESVILLE, FL · NPI 1881614139

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	254	77
Amlodipine Besylate	Amlodipine Besylate	251	69
Levothyroxine Sodium	Levothyroxine Sodium	192	52
Losartan Potassium	Losartan Potassium	186	63
Hydrochlorothiazide	Hydrochlorothiazide	168	47
Lisinopril	Lisinopril	166	48
Omeprazole	Omeprazole	161	47
Simvastatin	Simvastatin	158	38
Gabapentin	Gabapentin	127	31
Metformin Hcl	Metformin Hcl	117	32
Metoprolol Succinate	Metoprolol Succinate	116	31
Tamsulosin Hcl	Tamsulosin Hcl	107	28
Zolpidem Tartrate	Zolpidem Tartrate	103	21
Bupropion Xl	Bupropion Hcl	94	21
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	83	suppressed
Duloxetine Hcl	Duloxetine Hcl	82	15
Rosuvastatin Calcium	Rosuvastatin Calcium	82	28
Montelukast Sodium	Montelukast Sodium	81	25
Tramadol Hcl	Tramadol Hcl	78	23
Clonazepam	Clonazepam	77	13
Pravastatin Sodium	Pravastatin Sodium	76	23
Escitalopram Oxalate	Escitalopram Oxalate	74	23
Eliquis	Apixaban	68	19
Fluticasone Propionate	Fluticasone Propionate	62	24
Albuterol Sulfate Hfa	Albuterol Sulfate	59	23
Pantoprazole Sodium	Pantoprazole Sodium	55	20
Metoprolol Tartrate	Metoprolol Tartrate	53	18
Trazodone Hcl	Trazodone Hcl	53	18
Alprazolam	Alprazolam	52	suppressed
Furosemide	Furosemide	47	15
Allopurinol	Allopurinol	43	14
Potassium Chloride	Potassium Chloride	43	suppressed
Sertraline Hcl	Sertraline Hcl	43	13
Famotidine	Famotidine	41	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	14
Diazepam	Diazepam	40	suppressed
Finasteride	Finasteride	40	11
Ozempic	Semaglutide	40	suppressed
Lorazepam	Lorazepam	39	12
Oxycodone Hcl	Oxycodone Hcl	39	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	11
Meloxicam	Meloxicam	38	15
Alendronate Sodium	Alendronate Sodium	35	suppressed
Buspirone Hcl	Buspirone Hcl	34	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	34	suppressed
Glimepiride	Glimepiride	33	suppressed
Jardiance	Empagliflozin	33	suppressed
Temazepam	Temazepam	33	suppressed
Testosterone Cypionate	Testosterone Cypionate	33	suppressed
Carvedilol	Carvedilol	32	15
Promethazine Hcl	Promethazine Hcl	29	suppressed
Ibuprofen	Ibuprofen	28	suppressed
Metformin Hcl Er	Metformin Hcl	28	11
Mirtazapine	Mirtazapine	27	suppressed
Morphine Sulfate Er	Morphine Sulfate	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	suppressed
Valsartan	Valsartan	25	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Mometasone Furoate	Mometasone Furoate	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Ramipril	Ramipril	23	suppressed
Wegovy	Semaglutide	23	suppressed
Estradiol	Estradiol	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	22	suppressed
Raloxifene Hcl	Raloxifene Hcl	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Celecoxib	Celecoxib	20	suppressed
Clopidogrel	Clopidogrel Bisulfate	20	suppressed
Ondansetron Odt	Ondansetron	20	suppressed
Prednisone	Prednisone	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Topiramate	Topiramate	17	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Jantoven	Warfarin Sodium	16	suppressed
Testosterone	Testosterone	16	suppressed
Azithromycin	Azithromycin	15	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Nystatin	Nystatin	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Baclofen	Baclofen	12	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Atenolol	Atenolol	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error